Search Constraints
« Previous |
1 - 20 of 81
|
Next »
Search Results
Select an image to start the slideshow
Utilisation of rearrangement chemistry in the synthesis of novel fluorinated ring systems : a computational and experimental study
1 of 20
New treatments for inflammatory diseases : optimisation and understanding of key processes
2 of 20
The interplay of multiple ADME mechanisms : prediction of hepatic drug-drug interactions from in vitro
3 of 20
Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease
4 of 20
Pharmacological characterisation of small molecule RGD-mimetics targeting αvβ6-mediated activation of TGFβ in idiopathic pulmonary fibrosis
5 of 20
The use of structure-based drug design to optimise protein-ligand interactions
6 of 20
The design, synthesis and optimisation of CCR4 antagonists for the treatment of asthma
7 of 20
αV integrin antagonists for the treatment of idiopathic pulmonary fibrosis
8 of 20
The design, synthesis and optimisation of αvβ6 antagonists as potential idiopathic pulmonary fibrosis agents
9 of 20
Development of lysine-targeted irreversible inhibitors of PI3Kδ
10 of 20
Electrochemically enabled synthesis of substituted isoxazolines
11 of 20
Novel heterocyclic ligands for the lipid kinase PI4KIIIβ : a chemical biology approach
12 of 20
Chemoselective C-H functionalisation of aliphatic azacycles : utilisation of electrophilic iodine as a mild oxidant
13 of 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
14 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
15 of 20
Development of the C-methyltransferases NovO and CouO for biocatalytic Friedel-Crafts alkylation
16 of 20
The design, synthesis and optimisation of kinase inhibitors as potential anti-inflammatory agents
17 of 20
Studies and improvement of molecular docking methods in rigid and flexible receptors
18 of 20
Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models
19 of 20
Effects of OGG1 activation on mitochondrial function in response to oxidative stress
20 of 20